Skip to content

Universal Workflow
Bespoke Solutions.

Discover our Haemato-Oncology Integrated Genomic Solution.

A simple solution for the integrated genomic profiling of all haematological malignancies. Analyse mutations, fusion genes, copy number alterations and IG/TR rearrangements in an integrated report, with just 100ng of DNA.

The future of accurate genomic analysis

By encompassing all our NGS assays into a single universal workflow, you can achieve higher economy of scales and faster turnaround times for all your samples, irrespective of sample type or laboratory throughput.

EuroClonality NDC icon

EuroClonality NDC Assay

U8001
UniV8 Genomics logo EuroClonality logo

The EuroClonality-NDC Assay can detect IG/TR rearrangements and translocations, sequence variants and copy number alterations, all in a single test.

Designed and developed by the EuroClonality-NGS working group.

EuroClonality NDC Assay
Myeloid NDC icon

Myeloid
NDC
Assay

U8002
UniV8 Genomics logo

The Myeloid-NDC assay is intended for the integrated detection of chromosomal translocations, copy number variants (CNV) and sequence variants from suspected or confirmed cases of myeloid malignancies.

Myeloid NDC Assay

What our customers say

Maecenas sed diam eget risus varius blandit sit amet non magna. Vestibulum id ligula porta felis euismod semper. Praesent commodo cursus magna, vel scelerisque nisl consectetur et.

“We incorporated the EuroClonality-NDC assay for IG and TCR marker identification for MRD studies about a year ago. We have analysed more than 1000 samples so far and we are very happy with the results.”
Prof. Monika Brüggemann
Kiel University, Germany
“The EuroClonality-NDC assay is a really convenient and useful tool for lymphoma testing. In our institution, we started with a pilot research project and after few months we incorporated it into routine use.”
Dr Sarasquete and Dr Alcoceba
Salamanca University Hospital, Spain
“The EuroClonality-NDC assay offers and integrated and comprehensive assessment of the most important genomic aberrations required for routine diagnostic haematopathology practice...”
Dr Matthew Pugh
Consultant Haematopathologist, Birmingham and Wales, UK
“We incorporated the EuroClonality-NDC assay for IG and TCR marker identification for MRD studies about a year ago. We have analysed more than 1000 samples so far and we are very happy with the results.”
Prof. Monika Brüggemann
Kiel University, Germany
“The EuroClonality-NDC assay is a really convenient and useful tool for lymphoma testing. In our institution, we started with a pilot research project and after few months we incorporated it into routine use.”
Dr Sarasquete and Dr Alcoceba
Salamanca University Hospital, Spain
“The EuroClonality-NDC assay offers and integrated and comprehensive assessment of the most important genomic aberrations required for routine diagnostic haematopathology practice...”
Dr Matthew Pugh
Consultant Haematopathologist, Birmingham and Wales, UK

Updates